These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 34025576)
1. Selection for CD26 Molakandov K; Berti DA; Beck A; Elhanani O; Walker MD; Soen Y; Yavriyants K; Zimerman M; Volman E; Toledo I; Erukhimovich A; Levy AM; Hasson A; Itskovitz-Eldor J; Chebath J; Revel M Front Endocrinol (Lausanne); 2021; 12():635405. PubMed ID: 34025576 [TBL] [Abstract][Full Text] [Related]
2. Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo. Kim Y; Kim H; Ko UH; Oh Y; Lim A; Sohn JW; Shin JH; Kim H; Han YM Sci Rep; 2016 Oct; 6():35145. PubMed ID: 27731367 [TBL] [Abstract][Full Text] [Related]
3. Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes. Bose B; Shenoy SP; Konda S; Wangikar P Cell Biol Int; 2012 Nov; 36(11):1013-20. PubMed ID: 22897387 [TBL] [Abstract][Full Text] [Related]
4. Multipotent mesenchymal stromal cells enhance insulin secretion from human islets via N-cadherin interaction and prolong function of transplanted encapsulated islets in mice. Montanari E; Meier RPH; Mahou R; Seebach JD; Wandrey C; Gerber-Lemaire S; Buhler LH; Gonelle-Gispert C Stem Cell Res Ther; 2017 Sep; 8(1):199. PubMed ID: 28962589 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes. Hua XF; Wang YW; Tang YX; Yu SQ; Jin SH; Meng XM; Li HF; Liu FJ; Sun Q; Wang HY; Li JY PLoS One; 2014; 9(7):e102198. PubMed ID: 25009980 [TBL] [Abstract][Full Text] [Related]
10. In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells. Eshpeter A; Jiang J; Au M; Rajotte RV; Lu K; Lebkowski JS; Majumdar AS; Korbutt GS Cell Prolif; 2008 Dec; 41(6):843-858. PubMed ID: 19040565 [TBL] [Abstract][Full Text] [Related]
11. Co-culture with mature islet cells augments the differentiation of insulin-producing cells from pluripotent stem cells. Oh BJ; Oh SH; Choi JM; Jin SM; Shim WY; Lee MS; Lee MK; Kim KW; Kim JH Stem Cell Rev Rep; 2015 Feb; 11(1):62-74. PubMed ID: 25173880 [TBL] [Abstract][Full Text] [Related]
12. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus. Amer MG; Embaby AS; Karam RA; Amer MG Gene; 2018 May; 654():87-94. PubMed ID: 29452233 [TBL] [Abstract][Full Text] [Related]
13. Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo. Rezania A; Bruin JE; Xu J; Narayan K; Fox JK; O'Neil JJ; Kieffer TJ Stem Cells; 2013 Nov; 31(11):2432-42. PubMed ID: 23897760 [TBL] [Abstract][Full Text] [Related]
14. Light-stimulated insulin secretion from pancreatic islet-like organoids derived from human pluripotent stem cells. Choi J; Shin E; Lee J; Devarasou S; Kim D; Shin JH; Choi JH; Heo WD; Han YM Mol Ther; 2023 May; 31(5):1480-1495. PubMed ID: 36932674 [TBL] [Abstract][Full Text] [Related]
16. Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules. Kadam SS; Sudhakar M; Nair PD; Bhonde RR Cytotherapy; 2010 Dec; 12(8):982-91. PubMed ID: 20807019 [TBL] [Abstract][Full Text] [Related]
18. In vivo treatment with glucagon-like peptide 1 promotes the graft function of fetal islet-like cell clusters in transplanted mice. Suen PM; Li K; Chan JC; Leung PS Int J Biochem Cell Biol; 2006; 38(5-6):951-60. PubMed ID: 16172015 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells. Kim B; Yoon BS; Moon JH; Kim J; Jun EK; Lee JH; Kim JS; Baik CS; Kim A; Whang KY; You S Exp Mol Med; 2012 Jan; 44(1):26-35. PubMed ID: 22020533 [TBL] [Abstract][Full Text] [Related]
20. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis. Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]